Search
Menu
Home
HTB
2025
April
April 2025
Contents
Journal scan
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
Lancet Commission on gender justice and equality
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
People living with HIV need two shots of the mpox vaccine and likely a booster after two years
Early access
The RIO study: Q&A about controlling HIV with bNAbs
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
Conference reports
CROI 2025: Webcasts and other resources now open access
Continued reports from CROI 2025
CROI 2025: LAPTOP, EC rebounds after 32 years, two more HSCT cures
CROI 2025: Rebecca Denison gives opening community talk on 40 years of HIV
CROI 2025: BHIVA best of CROI feedback now online
CROI 2025: Two bNAbs enable viral suppression off-ART in African women in the FRESH cohort
Treatment access
Changes to US policy jeopardises the lives of 500,000 children living with HIV by 2030
Future meetings
Future meetings and webinars 2025
HTB RSS
Early access
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
All early access reports
Current issues
April 2025
March 2025
February 2025
Back issues
Special report
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate